Grants and Contributions:

Back to search

Title:

Vaccine and therapeutic target discovery effort: glycosylated RNAs on viruses

Agreement Number:

1015283

Agreement Value:

$24,998.00

Agreement Date:

Mar 26, 2024 - Mar 31, 2026

Description:

Advances exploratory research under the New Beginnings Initiative

Organization:

National Research Council Canada

Expected Results:

In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators.

Location:

Quebec, Quebec, CA G1K 9A9

Reference Number:

172-2023-2024-Q4-1015283

Agreement Type:

Grant

Report Type:

Grants and Contributions

Recipient Business Number:

108161266

Recipient Type:

Academia

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreement has been modified by 182 days.

Amendment Date

Jul 28, 2025

Recipient's Legal Name:

Institut national de la recherche scientifique

Federal Riding Name:

Québec Centre

Federal Riding Number:

24059

Program:

Collaborative Science, Technology and Innovation Program – Ideation Fund

Program Purpose:

The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.

NAICS Code:

541710

Amendments:

See Amendments